Publication

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Explore advances in model-informed precision dosing (MIPD) for pediatric antimicrobial therapy, including population PK modeling,…

CertaraJuly 29, 2026

Publication

Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate

See how QSP modeling guided the design of a reversible antibody switch that unmasks IL-12…

CertaraJuly 24, 2026

Poster

Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification

See how Simcyp Simulator V20–V24 DDI predictions were shown equivalent to the EMA-qualified V19 using…

CertaraJuly 24, 2026

Poster

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…

CertaraJuly 20, 2026

Publication

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data

QSP modeling reveals patient-specific factors driving CAR T-cell response and relapse in multiple myeloma, with…

CertaraJuly 20, 2026

Conference

EANM 2026

–

Danielle PillsburyJuly 20, 2026

Webinar

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Hunter Stephens, PhDJuly 17, 2026

Publication

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…

CertaraJuly 16, 2026

Blog

When to conduct hepatic impairment studies and when modeling may be enough

How to decide if a hepatic impairment study is required, choose the right study design,…

CertaraJuly 13, 2026

Conference

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

CertaraJuly 9, 2026

Modeling and Simulation

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate

Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data

EANM 2026

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

When to conduct hepatic impairment studies and when modeling may be enough

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Newsletter sign up

Quick links

Solutions

Contact